Cas:63817-45-8 2-[6-(1-ethylbenzo[cd]indol-1-ium-2-yl)-2,2,4-trimethyl-3,4-dihydroquinolin-1-yl]ethanol,chloride manufacturer & supplier

Chemical Name:2-[6-(1-ethylbenzo[cd]indol-1-ium-2-yl)-2,2,4-trimethyl-3,4-dihydroquinolin-1-yl]ethanol,chloride

CAS.NO:63817-45-8

Synonyms:einecs 264-497-8

Molecular Formula:C₂₇H₃₁ClN₂O

Molecular Weight:435.00100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:26.48000

Exact Mass:434.21200

LogP:2.46700

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like einecs 264-497-8 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,einecs 264-497-8 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,einecs 264-497-8 Use and application,einecs 264-497-8 technical grade,usp/ep/jp grade.

Related News: As further tools are created to improve biocatalyst development, these can likewise be assessed for their capacity to add value to a project. rel-(4R,5R)-3,3-dibutyl-9-(dimethylamino)-7-fluoro-4-hydroxy-5-phenyl-2,3,4,5-tetrahydrobenzo[b]thiepine 1,1-dioxide manufacturers India and China are two of the leading players in that game, and US legislators for months have pushed for an aggressive “onshoring” of drug production to counteract the nation’s reliance on foreign producers. Israel, a key ally to the US, could be a logical partner in that effort, but the Trump administration also took out big bets on US firms to set up shop stateside. 6-phenyl-pyridazine-3-carbaldehyde suppliers The PLI scheme aims to accelerate indigenous manufacturing of critical bulk drugs for which India is dependent on imports. Under this scheme government offered incentives varying between 10 to 20%. (2aS,2a1R,5aR,6R,8aR)-2,2,5a,8a-tetramethyldecahydro-2H-naphtho[1,8-bc]furan-6-ol vendor & factory The company pinpointed Thousand Oaks for its expansion “based on capability, staffing as well as the local community and the things we could bring to the area,” Hatke, told the news outlet.,India and China are two of the leading players in that game, and US legislators for months have pushed for an aggressive “onshoring” of drug production to counteract the nation’s reliance on foreign producers. Israel, a key ally to the US, could be a logical partner in that effort, but the Trump administration also took out big bets on US firms to set up shop stateside.